Published in Lab Business Week, May 14th, 2006
The offering, which raised gross proceeds of approximately $4.2 million, was completed pursuant to certain pre-existing contractual commitments of Amarin to investors that participated in a previously completed financing in May 2005. No additional shares will be sold pursuant to these contractual commitments.
Rick Stewart, CEO of Amarin commented, "Receipt of these additional funds from the investors in our May 2005...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week